Abstract
Pharmacogenetics is fundamental in the personalization of oncological therapy, enabling greater efficacy and safety by identifying genetic variants that influence the response to antineoplastic agents. The Brazilian population, characterized by its extensive admixture among Europeans, Africans, and Amerindians, exhibits genetic diversity that significantly impacts the frequencies of pharm…